These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6746112)

  • 1. Antigenic heterogeneity of clones and subclones from human melanoma cell lines demonstrated by a panel of monoclonal antibodies and flow microfluorometry analysis.
    Cillo C; Mach JP; Schreyer M; Carrel S
    Int J Cancer; 1984 Jul; 34(1):11-20. PubMed ID: 6746112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon gamma.
    Anichini A; Mortarini R; Fossati G; Parmiani G
    Int J Cancer; 1986 Oct; 38(4):505-11. PubMed ID: 3093392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies.
    Wikstrand CJ; Bigner SH; Bigner DD
    Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
    Houghton AN; Brooks H; Cote RJ; Taormina MC; Oettgen HF; Old LJ
    J Exp Med; 1983 Jul; 158(1):53-65. PubMed ID: 6864164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma.
    Carrel S; Schreyer M; Gross N; Zografos L
    Anticancer Res; 1990; 10(1):81-9. PubMed ID: 1692197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity and clonal variation related to cell surface expression of a mouse lung tumor-associated antigen quantified using flow cytometry.
    Bahler DW; Lord EM; Kennel SJ; Horan PK
    Cancer Res; 1984 Aug; 44(8):3317-23. PubMed ID: 6378365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigens.
    de Muralt B; de Tribolet N; Diserens AC; Stavrou D; Mach JP; Carrel S
    Eur J Cancer Clin Oncol; 1985 Feb; 21(2):207-16. PubMed ID: 2985398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function.
    Moretta A; Pantaleo G; Mingari MC; Moretta L; Cerottini JC
    J Exp Med; 1984 Mar; 159(3):921-34. PubMed ID: 6421984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoperoxidase staining of early human melanoma colonies with monoclonal antibodies. A new method for in vitro antigenic-morphologic correlation.
    Nakano GM; Natale RB; Lobuglio AF; Houghton AN
    Am J Pathol; 1984 Mar; 114(3):380-6. PubMed ID: 6364821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic heterogeneity of HLA products on human melanoma cells.
    Parmiani G; Taramelli D; Anichini A; Andreola S; Cascinelli N; Fossati G
    J Immunogenet; 1986; 13(2-3):235-40. PubMed ID: 3469277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma.
    Anichini A; Fossati G; Parmiani G
    Int J Cancer; 1985 May; 35(5):683-9. PubMed ID: 3158614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines.
    Carrel S; Schmidt-Kessen A; Mach JP; Heumann D; Girardet C
    J Immunol; 1983 May; 130(5):2456-60. PubMed ID: 6339629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.
    Wölfel T; Klehmann E; Müller C; Schütt KH; Meyer zum Büschenfelde KH; Knuth A
    J Exp Med; 1989 Sep; 170(3):797-810. PubMed ID: 2788708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.
    Kageshita T; Wang Z; Calorini L; Yoshii A; Kimura T; Ono T; Gattoni-Celli S; Ferrone S
    Cancer Res; 1993 Jul; 53(14):3349-54. PubMed ID: 7686817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
    Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
    Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-cycle-dependent expression of human melanoma membrane antigen analyzed by flow cytometry.
    Leong SP; Bolen JL; Chee DO; Smith VR; Taylor JC; Benfield JR; Klevecz RR
    Cancer; 1985 Mar; 55(6):1276-83. PubMed ID: 3882220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.
    Ferrini S; Miescher S; Zocchi MR; von Fliedner V; Moretta A
    J Immunol; 1987 Feb; 138(4):1297-302. PubMed ID: 3100633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.